Tag Archives: Office of Prescription Drug Promotion

Pharma's Social Media Struggles Continue

FDA has been rolling out new guidelines for using interactive media in recent months. The new guidances clarify some murky areas, but may not make online communications any easier. FDA’s Office of Prescription Drug Promotion (OPDP) provides some useful advice in its new advisories, which were discussed further in an OPDP webinar July 10. Overall, […]
Posted in Regulatory, social media | Also tagged , , | Leave a comment

US v. Caronia: What Constitutes 'Truthful' Speech?

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?
Posted in Advertising, compliance, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , , , , , , , , , , , | 1 Comment

Bristol-Myers Squibb's Summertime Blues

The sun was shining, savory scents were floating out from the grill, the lemonade was mixed and the table was set. But then dark clouds blew in and settled overhead. Bristol-Myers Squibb’s (BMS) picnic got rained out this summer. One element of the rain out was forecasted long ago; Plavix, the multibillion dollar blood-thinner, second […]
Posted in Advertising, Biotech, compliance, Deals, FDA, Legal, Marketing, pricing, R&D, Regulatory, Safety, Sales, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta